Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Basilea Pharmaceutica

Market Cap: CHF 666.0m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Rigel Pharmaceuticals

Market Cap: US$771.1m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹438.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Neuren Pharmaceuticals

Market Cap: AU$2.5b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Abbott India

Market Cap: ₹591.2b

Operates as a pharmaceutical company in India.

ChemoMetec

Market Cap: DKK 11.9b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Medpace Holdings

Market Cap: US$15.7b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

SK Biopharmaceuticals

Market Cap: ₩10.4t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Torrent Pharmaceuticals

Market Cap: ₹1.3t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

BioArctic

Market Cap: SEK 28.7b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Illumina

Market Cap: US$20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

PharmaResearch

Market Cap: ₩3.9t

Operates as a biopharmaceutical company primarily in South Korea.

Henan Lingrui Pharmaceutical

Market Cap: CN¥11.8b

Produces and sells medicines in China.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.8b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

Jiang Zhong PharmaceuticalLtd

Market Cap: CN¥15.4b

Engages in the manufacture of pharmaceutical products in China.

Blue Jet Healthcare

Market Cap: ₹94.0b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Consun Pharmaceutical Group

Market Cap: HK$12.4b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Middle East Pharmaceutical Industries

Market Cap: ر.س2.3b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

Ajanta Pharma

Market Cap: ₹324.2b

A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.

ACADIA Pharmaceuticals

Market Cap: US$4.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Lotus Pharmaceutical

Market Cap: NT$75.1b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

DHG Pharmaceutical

Market Cap: ₫13.5t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

Catalyst Pharmaceuticals

Market Cap: US$3.0b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Exelixis

Market Cap: US$11.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥45.3b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

Waters

Market Cap: US$22.9b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

argenx

Market Cap: €44.3b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Mega Lifesciences

Market Cap: ฿28.8b

Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

Shandong Wit Dyne HealthLtd

Market Cap: CN¥7.7b

Engages in the pharmaceutical business in China.

Incyte

Market Cap: US$19.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Genmab

Market Cap: DKK 124.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

WuXi AppTec

Market Cap: CN¥265.5b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Lupin

Market Cap: ₹954.5b

Operates as a pharmaceutical company in India, the United States, and internationally.

Pfizer

Market Cap: ₹229.7b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Gubra

Market Cap: DKK 8.1b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.